Discussions focus on integrating ECG diagnostics into AI-enabled E-ICU Command Centre and expanding technology-driven healthcare access across underserved regions
Collaboration integrates MERCURIUS DRUG-seq technologies with Revvity’s screening portfolio, enabling scalable transcriptomic profiling for next-generation drug discovery and AI-driven research
The FDA nod marks a step forward in precision oncology, linking molecular diagnostics more tightly to therapy selection for advanced prostate cancer
Acquisition strengthens integrated radiology and pathology capabilities, enhancing access to advanced diagnostics and preventive healthcare
The regulatory decision follows promising results from RIVER-81
KIHT can now conduct clinical research for drugs and medical devices, strengthening evidence generation and healthcare innovation
Enhanced CMC infrastructure at Cranbury site aims to improve bioavailability, streamline formulation development and support faster progression of challenging drug candidates into clinical trials
The Prayagraj lab is designed to handle both routine and specialised testing
Bengaluru-based startup will use the fresh capital to enter new markets, enhance technology capabilities, and scale its integrated care model
Subscribe To Our Newsletter & Stay Updated
